Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sporadic and hereditary amyotrophic lateral sclerosis (ALS)
Senda Ajroud‐Driss, Teepu Siddique
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1852, Iss. 4, pp. 679-684
Open Access | Times Cited: 195

Showing 1-25 of 195 citing articles:

How neuroinflammation contributes to neurodegeneration
Richard M. Ransohoff
Science (2016) Vol. 353, Iss. 6301, pp. 777-783
Closed Access | Times Cited: 1636
Compromised MAPK signaling in human diseases: an update
Eun‐Kyung Kim, Eui‐Ju Choi
Archives of Toxicology (2015) Vol. 89, Iss. 6, pp. 867-882
Closed Access | Times Cited: 919
Cytoplasmic stress granules: Dynamic modulators of cell signaling and disease
Hicham Mahboubi, Ursula Stochaj
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2017) Vol. 1863, Iss. 4, pp. 884-895
Closed Access | Times Cited: 259
Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases
Adam Armada‐Moreira, Joana I. Gomes, Carolina Campos Pina, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 239
Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders
Vladimir N. Uversky
Frontiers in Aging Neuroscience (2015) Vol. 7
Open Access | Times Cited: 183
Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases
Marcela Cruz-Haces, Jonathan Tang, Glen Acosta, et al.
Translational Neurodegeneration (2017) Vol. 6, Iss. 1
Open Access | Times Cited: 139
From animal models to human disease: a genetic approach for personalized medicine in ALS
Vincent Picher‐Martel, Paul N. Valdmanis, Peter V. Gould, et al.
Acta Neuropathologica Communications (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 135
Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis
Seshiru Nakazawa, Daisuke Oikawa, Ryohei Ishii, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 124
Antisense oligonucleotides in neurological disorders
Claudia D. Wurster, Albert C. Ludolph
Therapeutic Advances in Neurological Disorders (2018) Vol. 11, pp. 175628641877693-175628641877693
Open Access | Times Cited: 116
Autophagy in Age-Associated Neurodegeneration
Athanasios Metaxakis, Christina Ploumi, Nektarios Tavernarakis
Cells (2018) Vol. 7, Iss. 5, pp. 37-37
Open Access | Times Cited: 112
Proteasome activation: An innovative promising approach for delaying aging and retarding age-related diseases
Niki Chondrogianni, Konstantinos Voutetakis, Μαριάννα Καπετάνου, et al.
Ageing Research Reviews (2014) Vol. 23, pp. 37-55
Closed Access | Times Cited: 107
Mutant C9orf72 human iPSC‐derived astrocytes cause non‐cell autonomous motor neuron pathophysiology
Chen Zhao, Anna‐Claire Devlin, Amit K. Chouhan, et al.
Glia (2019) Vol. 68, Iss. 5, pp. 1046-1064
Open Access | Times Cited: 98
Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson’s disease brain
Benjamin G. Trist, Katherine M. Davies, Veronica Cottam, et al.
Acta Neuropathologica (2017) Vol. 134, Iss. 1, pp. 113-127
Open Access | Times Cited: 93
MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases
Mariano Catanesi, Michele d’Angelo, Maria Grazia Tupone, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5986-5986
Open Access | Times Cited: 87
Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications
Gargi Bhattacharjee, Nisarg Gohil, Khushal Khambhati, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 703-723
Closed Access | Times Cited: 55
SARM1: The Checkpoint of Axonal Degeneration in the Nervous System Disorders
Anushree Karnik, Abhijeet Joshi
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS)
Jonathan M. Van Dyke, Ivy M. Smit-Oistad, Corey Macrander, et al.
Experimental Neurology (2016) Vol. 277, pp. 275-282
Open Access | Times Cited: 78
Ubiquitin, Autophagy and Neurodegenerative Diseases
Yoshihisa Watanabe, Katsutoshi Taguchi, Masaki Tanaka
Cells (2020) Vol. 9, Iss. 9, pp. 2022-2022
Open Access | Times Cited: 70
A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS
Udaya Geetha Vijayakumar, Vanessa Milla, M. Stafford, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 65
New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models
Giovanni Nardo, Maria Chiara Trolese, Massimo Tortarolo, et al.
Brain Pathology (2016) Vol. 26, Iss. 2, pp. 237-247
Open Access | Times Cited: 62
Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis
Metka Ravnik‐Glavač, Damjan Glavač
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 5, pp. 1714-1714
Open Access | Times Cited: 60
The effects of diet and sex in amyotrophic lateral sclerosis
Jenny A. Pape, Julianne H. Grose
Revue Neurologique (2020) Vol. 176, Iss. 5, pp. 301-315
Open Access | Times Cited: 56
Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment
Michele Longoni Calió, Elisandra Henriques, Amanda Siena, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 56
Quercetin and Baicalein Act as Potent Antiamyloidogenic and Fibril Destabilizing Agents for SOD1 Fibrils
Nidhi Kaur Bhatia, Priya Modi, Shilpa Sharma, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 8, pp. 1129-1138
Closed Access | Times Cited: 55
Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders
Estela Área-Gómez, Delfina Larrea, Tianwei Yun, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top